OrganOx manufactures a medical device that keeps donor livers viable outside the body through warm perfusion—a shift from traditional cold storage. The tech stack (SAP, .NET/C#, SQL Server, Azure, React) reflects a manufacturing + software operation managing both hardware design (SolidWorks, ANSYS, Altium) and cloud-based logistics. Hiring velocity is accelerating with a strong engineering-to-ops ratio, and active projects cluster around supply-chain maturation, regulatory compliance, and clinical adoption—signals of scaling from development into sustained commercialization.
OrganOx, founded in 2008 as a University of Oxford spinout, develops the OrganOx metra®, a transportable device that preserves donor livers through normothermic machine perfusion—maintaining organ function at body temperature rather than cold storage. The approach enables objective assessment of organ viability before transplant and extends preservation windows, potentially recovering organs currently discarded. The company operates across the United Kingdom, United States, and Switzerland. Current priorities include second-source supplier development, physician training, supply-chain resilience, and regulatory compliance in transplant centers adopting the technology.
A transportable, automated device for liver preservation using normothermic (warm) perfusion at 37°C, mimicking the body's physiological environment. It maintains organ function, enables pre-transplant assessment, and extends preservation time compared to conventional cold storage.
Hardware design (SolidWorks, ANSYS, Altium), enterprise resource planning (SAP), cloud infrastructure (Azure), and full-stack web/mobile development (.NET, C#, React, TypeScript, React Native) for device monitoring and clinical workflow integration.
Other companies in the same industry, closest in size